Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

PublicNASDAQ:ENTA
Date4/2013
Raised$56M
Post IPO Valuation

General Information

Offices

Watertown, USA
500 Arsenal Street
Watertown, MA, 02472
USA

People

Chairman of the Supervisory Board
President, Chief Executive Officer and Director
Board of Directors
Board of Directors
Board of Directors
Board of Directors
Board of Directors
Board of Directors
Show All People

Funding

TOTAL $9.2M
FUNDING TOTAL $9.2M
Venture Round, 9/2013
$9.2M

Tags

Enanta Pharmaceuticals

Enanta Pharmaceuticals, Inc., a research and development company, engages in the discovery, development, and promotion of small molecule drugs in the areas of anti-infective.

It develops protease, NS5A, polymerase, and cyclophilin-based inhibitors for the treatment of hepatitis C virus (HCV). The company also develops ABT-450/r, an oral protease inhibitor for the treatment of hepatitis C (HCV) infection.

In addition, it develops Bicyclolides, a macrolide antibiotic, which overcomes bacterial resistance; and EDP-420, a bicyclolide antibiotic for the treatment of community-acquired pneumonia.

The company’s antibacterial focus areas include superbugs, respiratory tract infections, and intravenous and oral treatments for hospital and community MRSA.

The company has strategic alliances with Abbott Laboratories; and Shionogi & Co., LTD. Enanta Pharmaceuticals, Inc. was formerly known as NovirX, Inc. and changed its name to Enanta Pharmaceuticals, Inc. in May 1999.

The company was founded in 1998 and is based in Watertown, Massachusetts.

Recent Milestones

Videos

Screenshots

Enanta Pharmaceuticals screenshot
Above: Home Page
Uploaded: 2/22/12

Stock Price

Sources

  1. Enanta gets $9.2M to develop treatment for anthrax and other bioweapons (bizjournals.com) [edit]
  2. NIH awards $43M to Enanta to fight superbugs (masshightech.com) [edit]
    Enanta’s Hep C drug deal with Novartis worth up to $440M (masshightech.com) [edit]
Edit This Page
Last Edited 1/17/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy